If an adult patient has not lost at least 3% of baseline body weight or a pediatric patient has not experienced a reduction of at least 3% of baseline BMI, increase the dosage to QSYMIA 11.25 mg/69 mg orally once daily for 14 days
doi: 10.1016/j.ccr.2011.06.028
For queries, complaints, or support, please contact [email protected]
These decrease over time for most researchers
GLP-1 is not really physiologically essential for body weight but pharmacologically, has changed the field of obesity, said Daniel Drucker, a senior scientist at the Lunefield-Tanenbaum Research Institute who researches treatments for type 2 diabetes but was not affiliated with the new study
These advances represent a culmination of many years of scientific progress regarding our understanding of human weight regulation and the beginning of a new era in treating metabolic diseases